Giuseppe Pelosi, Valentina Melocchi, Elisa Dama, Paul Hofman, Marco De Luca, Adriana Albini, Maria Gemelli, Riccardo Ricotta, Mauro Papotti, Stefano La Rosa, Silvia Uccella, Sergio Harari, Angelica Sonzogni, Michael K Asiedu, Dennis A Wigle, Fabrizio Bianchi
Little is known as to whether there may be any pathogenetic link between pulmonary carcinoids and neuroendocrine carcinomas (NECs). A gene signature we previously found to cluster pulmonary carcinoids, large cell neuroendocrine carcinoma (LCNEC) and small cell lung carcinoma (SCLC), and which encompassed MEN1, MYC, MYCL1, RICTOR, RB1, SDHA, SRC and TP53 mutations or copy number variations (CNVs), was used to reclassify an independent cohort of 54 neuroendocrine neoplasms (NENs) [31 typical carcinoids (TC), 11 atypical carcinoids (AC) and 12 SCLC], by means of transcriptome and mutation data...
January 16, 2024: Experimental and Molecular Pathology